Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Federico Rojo
Based on 40 articles published since 2009
(Why 40 articles?)
||||
Expertise Level
The expertise of Federico Rojo ranks in the
  • Top 0.47%
  • ... of 263,954 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 40 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Rojo, F   ·   Rojo, Federico
Work Locations
Details
Most likely:    Universidad Autonoma de Madrid      
2019
  • Department of Medical Oncology, Hospital Clínico San Carlos, Madrid and Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, 02006, Albacete, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Department of Medical Oncology, Institut Català d'Oncologia (ICO)-IDIBELL, L'Hospitalet, Barcelona, Spain. · Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Institute of Biomedical Reasearch in Malaga, Malaga, Spain. · Department of Medical Oncology, Fundación Onkologikoa, Donostia, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Instituto de Biología Molecular y Celular del Cáncer, IBSAL, CSIC-Universidad de Salamanca, Salamanca, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 30607629
2018
  • Departamento de Oncología Médica, Hospital Universitario La Princesa, C/Diego de León, 62, 28006, Madrid, Spain. · Pathology Department, General University Hospital of Alicante, Alicante, Spain. · Medical Oncology Department, Mar University Hospital, Hospital del Mar Medical Research Institute (IMIM), Pompeu Fabra University, CIBERONC, Barcelona, Spain. · Pathology Department, University Hospital Complex of Santiago, Santiago de Compostela, Spain. · Medical Oncology Department, Doce de Octubre University Hospital, Madrid, Spain. · Pathology Department, Virgen del Rocio University Hospital, CIBERONC, Seville, Spain. · Medical Oncology Department, Ramón y Cajal University Hospital, Madrid, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Baselga Institute of Oncology (IOB), Madrid, Barcelona, Spain. · Pathology Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain. · Medical Oncology Department, Gregorio Marañón University Hospital, CIBERONC, GEICAM, Madrid, Spain. · Pathology Department, Ramón y Cajal University Hospital, CIBERONC, IRYCIS and University of Alcalá, Madrid, Spain. · Pubmed 29273958
  • Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy; Medical Oncology 2, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy. Electronic address: · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France; Inserm/University of Auvergne U1240, Clermont-Ferrand, France. · Montefiore Medical Center, Bronx, NY, USA; The Albert Einstein College of Medicine, Bronx, NY, USA. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Department of Pathology, GZA Ziekenhuizen, Antwerp, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, B2 M, RdC,114 rue Edouard-Vaillant, 94805, Villejuif, France; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, 94805, France. · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France; Inserm/University of Auvergne U1240, Clermont-Ferrand, France; School of Medicine, University of Auvergne, Clermont-Ferrand, France. · Division of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA. · Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA. · Department of Research, Instituto Nacional de Enfermedades Neoplasicas, Lima 15038, Peru. · Department of Pathology and Laboratory, Medicine, Indiana University, Indianapolis, USA. · Department of Pathology, Yale University School of Medicine, New Haven, USA. · Pathology Department, IIS, Fundacion Jimenez Diaz, UAM, Madrid, Spain. · Department of Pathology, Coney Island Hospital, NY, USA. · Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. · Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA, USA. · Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA. · dlw Laborsoftware UG (haftungsbeschränkt) Lübben, Germany. · German Breast Group, Neu-Isenburg, Germany. · Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, USA. · Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · New York University Medical School, Perlmutter Cancer Center, NY, USA. · Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. · Translational Breast Cancer Genomic and Therapeutics Laboratory, Peter Mac Callum Cancer Center, Victoria, Australia; Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Brussels, Belgium; Department of Pathology, GZA, Antwerp, Belgium. · Pubmed 29024776
  • Group of Cancer Biomarkers, Pathology Department, Health Research Institute Fundacion Jimenez Diaz, UAM (IIS-FJD, UAM), Avda. Reyes Catolicos, E-28040 Madrid, Spain. · Medical Oncology Department, Oncohealth Institute, Health Research Institute Fundacion Jimenez Diaz, UAM (IIS-FJD, UAM), Avda. Reyes Catolicos, E-28040 Madrid, Spain. · Cancer Research Program, Hospital del Mar Research Institute (IMIM), Medical Oncology Department, Hospital del Mar, E-08003 Barcelona, Spain. · Oncology and Hematology Department, Health Research Institute University Clinic Hospital of Valencia (INCLIVA), University of Valencia, E-46010 Valencia, Spain. · Pubmed 27993109
  • Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia. · The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia. · St Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, NSW, 2010, Australia. · The Chris O' Brien Lifehouse, Camperdown, NSW, 2050, Australia. · Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia. · MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Bristol, BS8 2BN, UK. · Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, SA, 5000, Australia. · Faculty of Health Sciences, School of Medicine, University of Adelaide, Adelaide, SA, 5000, Australia. · Pathology Queensland and School of Medicine, University of Queensland, St Lucia, QLD, 4006, Australia. · Rajiv Gandhi Centre for Biotechnology, Thycaud Post, Poojappura, Thiruvananthapuram, Kerala, 695014, India. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, 41013, Sevilla, Spain. · Department of Pathology, Hospital Universitario Fundación Jiménez Díaz, 28040, Madrid, Spain. · Department of Medical Oncology, Hospital Clínico Universitario Virgen de la Victoria, IBIMA, 29010, Málaga, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, 28703, Spain. · St Vincent's Hospital, 2010, Darlinghurst, NSW, Australia. · Department of Medical Oncology, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, 28040, Madrid, Spain. · Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia. · The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia. · St Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, NSW, 2010, Australia. · Pubmed 30042390
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. Electronic address: · Medical Oncology Service, Hospital Universitario Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Department of Pathology, Seoul National University Bundang Hospital, 82, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam, Gyeonggi 13620, Republic of Korea; Inivata, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. · Inivata UK, The Portway Building, Granta Park, Cambridge CB21 6GS, UK. · Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ, UK. · Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. · Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain; GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain. · Medical Oncology Service, Hospital Universitario Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain; Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. Electronic address: · Pubmed 29608913
  • Departamento de Anatomía Patológica, Hospital Universitario Ramón y Cajal, CIBERONC, IRYCIS, Universidad de Alcalá, Madrid, España. Electronic address: · Departamento de Oncología Médica, Hospital del Mar, Instituto de Investigación Médica del Hospital del Mar (IMIM), Universidad Pompeu Fabra, CIBERONC, Barcelona, España. · Departamento de Anatomía Patológica, Hospital Universitario Fundación Jiménez Díaz, Madrid, España. · Departamento de Oncología Médica, Hospital Universitario 12 de Octubre, Madrid, España. · Departamento de Anatomía Patológica, Hospital General Universitario de Alicante, Alicante, España. · Departamento de Oncología Médica, Hospital Universitario Ramón y Cajal, Madrid, España; Instituto de Oncología Vall d'Hebron (VHIO), Instituto de Oncología Baselga (IOB), Barcelona, España. · Departamento de Anatomía Patológica, Complexo Hospitalario de Santiago, Santiago de Compostela, La Coruña, España. · Departamento de Oncología Médica, Hospital Universitario Gregorio Marañón, CIBERONC, GEICAM, Madrid, España. · Departamento de Anatomía Patológica, Hospital Universitario Virgen del Rocío, CIBERONC, Sevilla, España. · Departamento de Oncología Médica, Hospital Universitario de la Princesa, Madrid, España. · Pubmed 29602380
  • Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. · CIBERONC, Madrid, Spain. · Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. · Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain. · Translational Genomics and Targeted Therapeutics, Institut d'Investigacions Biomèdiques Pi i Sunyer-IDIBAPS, Barcelona, Spain. · Experimental Therapeutics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain. · Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. · Department of Pathology, Yale University School of Medicine, Yale, CT, USA. · Department of Oncology, Vall d'Hebrón University Hospital, Barcelona, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Universitat Autònoma de Barcelona, Bellaterra, Spain. · ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain. · Ramon y Cajal University Hospital, Madrid, Spain. · Medical Oncology Service, Hospital del Mar, Barcelona, Spain. · Department of Oncology, Hospital Clinic de Barcelona, Barcelona, Spain. · Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain. · University of Valencia, Valencia, Spain. · INCLIVA, Instituto de Investigación Sanitaria, Valencia, Spain. · Universitat Pompeu Fabra, Barcelona, Spain. · Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. · CIBERONC, Madrid, Spain. · ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain. · Universitat de Barcelona, Barcelona, Spain. · Pubmed 29358704
2017
  • Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz, UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, Spain. Electronic address: · Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz, UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, Spain. · Pathology Department, IIS "Fundación Jiménez Diaz", Madrid, Spain. · Pathology Department, IIS "Fundación Jiménez Diaz", Madrid, Spain. Electronic address: · Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz, UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, Spain. Electronic address: · Pubmed 28916342
  • Hospital Universitario Virgen Macarena, Seville, Spain. Electronic address: · GEICAM (Spanish Breast Cancer Research Group), Madrid, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Medical School, Hospital Universitario Virgen Macarena, Seville, Spain. · Pubmed 28325210
  • Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK. Electronic address: · Clinical Trials Research Unit, University of Leeds, Leeds, UK. · IMIM-CIBERONC, Barcelona; Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain. · Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Deakin University, Geelong, VIC, Australia. · Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK. · St James Institute of Oncology, St James Hospital, Leeds, UK. · Inbiomotion, Barcelona, Spain. · Fundación Jiménez Díaz, Madrid, Spain; CIBERONC, Madrid, Spain. · IMIM-CIBERONC, Barcelona; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. · Pubmed 29037984
  • Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain, on behalf of GEICAM (Spanish Breast Cancer Group), Spain. · Oncology Department, Hospital Universitario Virgen de la Salud, Toledo, Spain. · Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Oncology Department, Onkologikoa, San Sebastián, Spain. · Oncology Department, Hospital General Universitario Morales Messeguer, Murcia, Spain. · Oncology Department, Corporación Sanitaria Parc Taulí, Barcelona, Spain. · Oncology Department, Complejo Hospitalario de Jaén, Jaén, Spain. · Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Oncology Department, Complejo Hospitalario Universitario de la Coruña, La Coruña, Spain. · Oncology Department, Hospital Universitario la Paz, Madrid, Spain. · Medical Oncology Department, Hospital de Santa Creu i Sant Pau, Institut de Recerca IIB Sant Pau, Barcelona, Spain. · Oncology Department, Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife, Spain. · Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain. · Oncology Department, Hospital Clinic i Provincial, Barcelona, Spain. · GEICAM headquarters, Madrid, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 28701571
  • Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Medical Oncology Department, Hospital del Mar- CIBERONC, Barcelona, Spain. · Centro de Investigación del Cáncer, Universidad de Salamanca-CSIC-CIBERONC, Salamanca, Spain. · Pathology Department, Hospital del Mar, Barcelona, Spain. · Immunity and infection Laboratory, IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Pathology Department, IIS-Fundación Jiménez Díaz- CIBERONC, Madrid, Spain. · INCLIVA Biomedical Research Institute, Valencia, Spain. · Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO)-CIBERONC, Barcelona, Spain. · Autonomous University of Barcelona, Barcelona, Spain. · Institució Catalana de Recerca I Estudis Avançats (ICREA), Barcelona, Spain. · Oncology and Hematology Department, Hospital Clínico Universitario-CIBERONC, Valencia, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Universitat Pompeu Fabra, Barcelona, Spain. · Pubmed 28821558
  • Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain. · Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy. · Medical Oncology Deparment, Arnau de Vilanova de Lleida Universitary Hospital, Lleida, Spain. · Medical Oncology Department, Reina Sofía University Hospital, Cordoba, Spain. · Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Universidad Complutense, Madrid, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Medical Oncology Department, Quirón Hospital, Madrid, Spain. · Master of Breast Pathology, University of Barcelona, Barcelona, Spain. · Pathology Department, Fundación Jiménez Díaz Health Research Institute (IIS-FJD), Madrid, Spain. · Medical Oncology Department, Doce de Octubre Hospital, Madrid, Spain. · Medical Oncology Department, Hospital del Mar, Barcelona, Spain. · Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain. · Medical Oncology Department, Mutua de Terrassa Hospital, Barcelona, Spain. · Spanish Breast Cancer Research Group Grupo Español de Investigación en Cáncer de Mama (GEICAM), Madrid, Spain. · Pubmed 28423537
  • Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain. · Hospital Provincial de Castellón, Castellón, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Pathology, Hospital Clínico Universitario de Valencia, Spain. · Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Hospital Clínico San Cecilio, Complejo Hospitalario de Granada, Granada, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Universitario Quirón de Madrid, Madrid, Spain. · Hospital Virgen de la Salud, Toledo, Spain. · Pathology Department, Hospital Vall d'Hebron, Barcelona, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · University of North Carolina, Chapel Hill, North Carolina. · Ramón y Cajal University Hospital, Madrid, Spain. · University of Messina, Messina, Italy. · Hospital del Mar, Barcelona, Spain. · ICREA, Barcelona, Spain. · Department of Hematology and Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Pubmed 28249905
  • INCLIVA Biomedical Research Institute, 46010 Valencia, Spain. · Pathology Department, IIS-Fundación Jiménez Díaz, 28040 Madrid, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), 08003 Barcelona, Spain. · Medical Oncology Department, Hospital del Mar, 08003 Barcelona, Spain. · Pompeu Fabra University, 08002 Barcelona, Spain. · Oncology and Hematology Department, Hospital Clínico Universitario, 46010 Valencia, Spain. · Pubmed 28120942
  • Department of Medical Oncology, Translational Oncology Division, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital 'Fundacion Jimenez Diaz', Madrid, Spain. · Department of Pathology, IIS 'Fundación Jiménez Diaz', Madrid, Spain. · Department of Breast Cancer Research, Institute of Health Research INCLIVA, Valencia, Spain. · Department of Medical Oncology, Hospital del Mar, Barcelona, Spain. · Pubmed 28068327
  • Translational Oncology DivisionOncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital 'Fundacion Jimenez Diaz', Madrid, Spain · Translational Oncology DivisionOncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital 'Fundacion Jimenez Diaz', Madrid, Spain. · Pathology DepartmentIIS-Fundacion Jimenez Diaz-UAM, University Hospital 'Fundacion Jimenez Diaz', Madrid, Spain. · Pubmed 27765801
2016
  • Pathology Department, IIS-Fundación Jiménez Díaz, UAM, Madrid, Spain. · Translational Oncology Division, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital Fundación Jiménez Díaz, Madrid, Spain. · "Alberto Sols" Biomedical Research Institute CSIC-UAM, Madrid, Spain. · Institute of Health Research INCLIVA, Valencia, Spain. · Medical Oncology Department, Hospital del Mar, Barcelona, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Universitat Pompeu Fabra, Barcelona, Spain. · Pathology Department, IIS-Fundación Jiménez Díaz, UAM, Madrid, Spain. · Pubmed 27599524
  • Pathology Department, IIS-Fundación Jiménez Díaz, 28040 Madrid, Spain. · Research Unit on Biomedical Informatics-GRIB, IMIM 08003 Barcelona, Spain. · INCLIVA Biomedical Research Institute, 46010 Valencia, Spain. · Pathology Department Hospital General Universitario de Castellón, 12004 Castellón, Spain. · Pathology Department, Hospital Clinico Universitario, 46010 Valencia, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), 08003 Barcelona, Spain. · Medical Oncology Department, Hospital del Mar, 08003 Barcelona, Spain. · Universitat Pompeu Fabra, 08002 Barcelona, Spain. · Oncology and Hematology Department, Hospital Clinico Universitario, 46010 Valencia, Spain. · Pubmed 27404455
  • Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona 08028, Spain. · Cancer Research Programme, IMIM (Hospital del Mar Medical Research Institute), Barcelona 08003 Spain. · Pathology Department, IIS-Fundación Jimenez Diaz, Madrid 28040, Spain. · Centre for Omic Sciences, Universitat Rovira i Virgili, Reus 43204, Spain. · Department of Electronic Engineering, Universitat Rovira i Virgili, Tarragona 43003, Spain. · Spanish Biomedical Research Center in Diabetes and Associated Metabolic Disorders (CIBERDEM), Madrid 28029, Spain. · Medical Oncology Service, Hospital del Mar, Barcelona 08003, Spain. · Medical Oncology Service, Hospital Clinico, Valencia 46010, Spain. · Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona 08010, Spain. · Universitat Pompeu Fabra, Barcelona 08003, Spain. · Department of Biochemistry and Molecular Biology, Universitat de Barcelona, Barcelona 08028, Spain. · Pubmed 27045898
  • Virgen de la Victoria University Hospital, Málaga, Spain · Valencia University Hospital, Valencia, Spain. · Virgen de la Victoria University Hospital, Málaga, Spain. · Miguel Servet University Hospital, Zaragoza, Spain. · Jaén Hospital Complex, Jaen, Spain. · Hospital del Mar Medical Research Institute-Institut Hospital del Mar d'Investigacions Mediques and Pompeu Fabra University, Barcelona, Spain. · A Coruña University Hospital Complex, A Coruña, Spain. · San Carlos University Hospial, Madrid, Spain. · Ramón y Cajal University Hospital, Madrid, Spain. · Virgen de la Salud Hospital, Toledo, Spain. · Valencian Institute of Oncology, Valencia, Spain. · Biomedical Research Institute, Reina Sofía Hospital Complex, Córdoba, Spain. · Parc Taulí Health Corporation, Barcelona, Spain. · Germans Trias i Pujol University Hospital, Barcelona, Spain. · Onkologikoa, Donostia, Spain. · Santa Creu i Sant Pau Hospital, Barcelona, Spain. · GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain. · Fundación Jiménez Diaz University Hospital, Madrid, Spain. · Pubmed 26786263
2015
  • Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain · Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain · Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR) · Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA) · Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL) · Valencia Central University, Spain (AL) · Inbiomotion, Barcelona, Spain (JJM) · Sheffield Cancer Research Centre, Sheffield, UK (RC) · Universitat Pompeu Fabra, Barcelona, Spain (JA) · Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP) · Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA) · Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG). · Pubmed 26376684
  • Translational Oncology Division, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital "Fundación Jiménez Diaz", Madrid, Spain. · Pathology Department, IIS "Fundación Jiménez Diaz", Madrid, Spain. · Medical Oncology Department, Hospital del Mar, Barcelona, Spain. · Institute of Health Research INCLIVA, Valencia, Spain. · Pubmed 25726524
2014
  • Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga 29010, Spain. · Hospital Parc de Salut Mar, 8003 Barcelona, Spain. · Hospital Universitario Reina Sofía, 14004 Córdoba, Spain. · Hospital Santa Creu i Sant Pau, Universidad Autónoma de Barcelona, 8041 Barcelona, Spain. · Complejo Hospitalario Universitario de A Coruña, 15006A Coruña, Spain. · Hospital General de Jaén, 23007 Jaén, Spain. · Centro Oncológico de Galicia, 15009A Coruña, Spain. · 1] Hospital Parc de Salut Mar, 8003 Barcelona, Spain [2] Department of Pathology, Fundación Jiménez Díaz, 28040 Madrid, Spain. · Department of Pathology and Oncology, Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain. · GEICAM (Spanish Breast Cancer Research Group), 28703 Madrid, Spain. · Pubmed 24457911
  • Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain; Medical Oncology Department, Hospital del Mar, Barcelona, Spain. · Preclinical Research Program, Valld'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pathology Department, IIS-Fundación Jiménez Díaz, Madrid, Spain. · Institute of Health Research INCLIVA, Valencia, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain; Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Autonomous University of Barcelona, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain; Immunology Department, Hospital del Mar, Barcelona, Spain. · Oncology and Hematology Department, Hospital Clinico Universitario, Valencia, Spain; Valencia Central University, Spain. · Preclinical Research Program, Valld'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Department of Biochemistry and Molecular Biology, Universitat Autonoma de Barcelona, Bellaterra, Spain; Institució Catalana de Recerca I Estudis Avançats (ICREA), Barcelona, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jiménez Díaz, Madrid, Spain; Pathology Department, Hospital del Mar, Barcelona, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain; Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain. Electronic address: · Pubmed 25128455
  • Authors' Affiliations: Departments of Pathology and Immunology, IIS-Fundación Jiménez Díaz, Madrid; Cancer Research Program; Microarray Core Facility (SAM), IMIM (Hospital del Mar Medical Research Institute); Department of Epidemiology and Evaluation, Hospital del Mar; Research Network on Health Services in Chronic Diseases (REDISSEC); Departments of Pathology, Medical Oncology, and Radiology Department, Hospital del Mar; and Universitat Pompeu Fabra, Barcelona, Spain. · Pubmed 24347552
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
2016
  • Group of Cancer Biomarkers, Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain. · Pubmed 25789534
2013
  • Molecular Immunology Unit, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain. · Pubmed 23951338
Probable:    Instituto de Salud Carlos III      
2019
  • Department of Medical Oncology, Hospital Clínico San Carlos, Madrid and Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, 02006, Albacete, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Department of Medical Oncology, Institut Català d'Oncologia (ICO)-IDIBELL, L'Hospitalet, Barcelona, Spain. · Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Institute of Biomedical Reasearch in Malaga, Malaga, Spain. · Department of Medical Oncology, Fundación Onkologikoa, Donostia, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Instituto de Biología Molecular y Celular del Cáncer, IBSAL, CSIC-Universidad de Salamanca, Salamanca, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 30607629
2018
  • Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. · CIBERONC, Madrid, Spain. · Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. · Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain. · Translational Genomics and Targeted Therapeutics, Institut d'Investigacions Biomèdiques Pi i Sunyer-IDIBAPS, Barcelona, Spain. · Experimental Therapeutics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain. · Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. · Department of Pathology, Yale University School of Medicine, Yale, CT, USA. · Department of Oncology, Vall d'Hebrón University Hospital, Barcelona, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Universitat Autònoma de Barcelona, Bellaterra, Spain. · ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain. · Ramon y Cajal University Hospital, Madrid, Spain. · Medical Oncology Service, Hospital del Mar, Barcelona, Spain. · Department of Oncology, Hospital Clinic de Barcelona, Barcelona, Spain. · Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain. · University of Valencia, Valencia, Spain. · INCLIVA, Instituto de Investigación Sanitaria, Valencia, Spain. · Universitat Pompeu Fabra, Barcelona, Spain. · Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. · CIBERONC, Madrid, Spain. · ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain. · Universitat de Barcelona, Barcelona, Spain. · Pubmed 29358704
2017
  • Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK. Electronic address: · Clinical Trials Research Unit, University of Leeds, Leeds, UK. · IMIM-CIBERONC, Barcelona; Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain. · Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Deakin University, Geelong, VIC, Australia. · Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK. · St James Institute of Oncology, St James Hospital, Leeds, UK. · Inbiomotion, Barcelona, Spain. · Fundación Jiménez Díaz, Madrid, Spain; CIBERONC, Madrid, Spain. · IMIM-CIBERONC, Barcelona; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. · Pubmed 29037984
  • Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain, on behalf of GEICAM (Spanish Breast Cancer Group), Spain. · Oncology Department, Hospital Universitario Virgen de la Salud, Toledo, Spain. · Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Oncology Department, Onkologikoa, San Sebastián, Spain. · Oncology Department, Hospital General Universitario Morales Messeguer, Murcia, Spain. · Oncology Department, Corporación Sanitaria Parc Taulí, Barcelona, Spain. · Oncology Department, Complejo Hospitalario de Jaén, Jaén, Spain. · Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Oncology Department, Complejo Hospitalario Universitario de la Coruña, La Coruña, Spain. · Oncology Department, Hospital Universitario la Paz, Madrid, Spain. · Medical Oncology Department, Hospital de Santa Creu i Sant Pau, Institut de Recerca IIB Sant Pau, Barcelona, Spain. · Oncology Department, Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife, Spain. · Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain. · Oncology Department, Hospital Clinic i Provincial, Barcelona, Spain. · GEICAM headquarters, Madrid, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 28701571
  • Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Medical Oncology Department, Hospital del Mar- CIBERONC, Barcelona, Spain. · Centro de Investigación del Cáncer, Universidad de Salamanca-CSIC-CIBERONC, Salamanca, Spain. · Pathology Department, Hospital del Mar, Barcelona, Spain. · Immunity and infection Laboratory, IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Pathology Department, IIS-Fundación Jiménez Díaz- CIBERONC, Madrid, Spain. · INCLIVA Biomedical Research Institute, Valencia, Spain. · Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO)-CIBERONC, Barcelona, Spain. · Autonomous University of Barcelona, Barcelona, Spain. · Institució Catalana de Recerca I Estudis Avançats (ICREA), Barcelona, Spain. · Oncology and Hematology Department, Hospital Clínico Universitario-CIBERONC, Valencia, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Universitat Pompeu Fabra, Barcelona, Spain. · Pubmed 28821558
  • Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain. · Hospital Provincial de Castellón, Castellón, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Pathology, Hospital Clínico Universitario de Valencia, Spain. · Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Hospital Clínico San Cecilio, Complejo Hospitalario de Granada, Granada, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Universitario Quirón de Madrid, Madrid, Spain. · Hospital Virgen de la Salud, Toledo, Spain. · Pathology Department, Hospital Vall d'Hebron, Barcelona, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · University of North Carolina, Chapel Hill, North Carolina. · Ramón y Cajal University Hospital, Madrid, Spain. · University of Messina, Messina, Italy. · Hospital del Mar, Barcelona, Spain. · ICREA, Barcelona, Spain. · Department of Hematology and Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Pubmed 28249905
Probable:    Miscellaneous institutions in Madrid      
2019
  • Department of Medical Oncology, Hospital Clínico San Carlos, Madrid and Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, 02006, Albacete, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Department of Medical Oncology, Institut Català d'Oncologia (ICO)-IDIBELL, L'Hospitalet, Barcelona, Spain. · Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Institute of Biomedical Reasearch in Malaga, Malaga, Spain. · Department of Medical Oncology, Fundación Onkologikoa, Donostia, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Instituto de Biología Molecular y Celular del Cáncer, IBSAL, CSIC-Universidad de Salamanca, Salamanca, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 30607629
2017
  • Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain. · Hospital Provincial de Castellón, Castellón, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Pathology, Hospital Clínico Universitario de Valencia, Spain. · Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Hospital Clínico San Cecilio, Complejo Hospitalario de Granada, Granada, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Universitario Quirón de Madrid, Madrid, Spain. · Hospital Virgen de la Salud, Toledo, Spain. · Pathology Department, Hospital Vall d'Hebron, Barcelona, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · University of North Carolina, Chapel Hill, North Carolina. · Ramón y Cajal University Hospital, Madrid, Spain. · University of Messina, Messina, Italy. · Hospital del Mar, Barcelona, Spain. · ICREA, Barcelona, Spain. · Department of Hematology and Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Pubmed 28249905
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 40 total) written by Federico Rojo about Breast Neoplasms:

  • Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study. 2019
  • Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology. 2018
  • Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer. 2018
  • Recent Insights into the Development of Preclinical Trastuzumab- Resistant HER2+ Breast Cancer Models. 2018
  • Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer. 2018
  • Shallow whole genome sequencing for robust copy number profiling of formalin-fixed paraffin-embedded breast cancers. 2018
  • [Consensus statement on biomarkers in breast cancer by the Spanish Society of Pathology and the Spanish Society of Medical Oncology]. 2018
  • MSK1 regulates luminal cell differentiation and metastatic dormancy in ER 2018
  • PP2A regulates signaling through hormonal receptors in breast cancer with important therapeutic implications. 2017
  • Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research. 2017
Show List of Full Article Records
Google Searches

Learn more about Federico Rojo using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Universidad Autonoma de Madrid
Instituto de Salud Carlos III
Miscellaneous institutions in Madrid
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Universidad Autonoma de Madrid
2019
  • Department of Medical Oncology, Hospital Clínico San Carlos, Madrid and Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, 02006, Albacete, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Department of Medical Oncology, Institut Català d'Oncologia (ICO)-IDIBELL, L'Hospitalet, Barcelona, Spain. · Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Institute of Biomedical Reasearch in Malaga, Malaga, Spain. · Department of Medical Oncology, Fundación Onkologikoa, Donostia, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Instituto de Biología Molecular y Celular del Cáncer, IBSAL, CSIC-Universidad de Salamanca, Salamanca, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 30607629
2018
  • Departamento de Oncología Médica, Hospital Universitario La Princesa, C/Diego de León, 62, 28006, Madrid, Spain. · Pathology Department, General University Hospital of Alicante, Alicante, Spain. · Medical Oncology Department, Mar University Hospital, Hospital del Mar Medical Research Institute (IMIM), Pompeu Fabra University, CIBERONC, Barcelona, Spain. · Pathology Department, University Hospital Complex of Santiago, Santiago de Compostela, Spain. · Medical Oncology Department, Doce de Octubre University Hospital, Madrid, Spain. · Pathology Department, Virgen del Rocio University Hospital, CIBERONC, Seville, Spain. · Medical Oncology Department, Ramón y Cajal University Hospital, Madrid, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Baselga Institute of Oncology (IOB), Madrid, Barcelona, Spain. · Pathology Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain. · Medical Oncology Department, Gregorio Marañón University Hospital, CIBERONC, GEICAM, Madrid, Spain. · Pathology Department, Ramón y Cajal University Hospital, CIBERONC, IRYCIS and University of Alcalá, Madrid, Spain. · Pubmed 29273958
  • Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy; Medical Oncology 2, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy. Electronic address: · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France; Inserm/University of Auvergne U1240, Clermont-Ferrand, France. · Montefiore Medical Center, Bronx, NY, USA; The Albert Einstein College of Medicine, Bronx, NY, USA. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Department of Pathology, GZA Ziekenhuizen, Antwerp, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, B2 M, RdC,114 rue Edouard-Vaillant, 94805, Villejuif, France; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, 94805, France. · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France; Inserm/University of Auvergne U1240, Clermont-Ferrand, France; School of Medicine, University of Auvergne, Clermont-Ferrand, France. · Division of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA. · Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA. · Department of Research, Instituto Nacional de Enfermedades Neoplasicas, Lima 15038, Peru. · Department of Pathology and Laboratory, Medicine, Indiana University, Indianapolis, USA. · Department of Pathology, Yale University School of Medicine, New Haven, USA. · Pathology Department, IIS, Fundacion Jimenez Diaz, UAM, Madrid, Spain. · Department of Pathology, Coney Island Hospital, NY, USA. · Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. · Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA, USA. · Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA. · dlw Laborsoftware UG (haftungsbeschränkt) Lübben, Germany. · German Breast Group, Neu-Isenburg, Germany. · Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, USA. · Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · New York University Medical School, Perlmutter Cancer Center, NY, USA. · Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. · Translational Breast Cancer Genomic and Therapeutics Laboratory, Peter Mac Callum Cancer Center, Victoria, Australia; Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Brussels, Belgium; Department of Pathology, GZA, Antwerp, Belgium. · Pubmed 29024776
  • Group of Cancer Biomarkers, Pathology Department, Health Research Institute Fundacion Jimenez Diaz, UAM (IIS-FJD, UAM), Avda. Reyes Catolicos, E-28040 Madrid, Spain. · Medical Oncology Department, Oncohealth Institute, Health Research Institute Fundacion Jimenez Diaz, UAM (IIS-FJD, UAM), Avda. Reyes Catolicos, E-28040 Madrid, Spain. · Cancer Research Program, Hospital del Mar Research Institute (IMIM), Medical Oncology Department, Hospital del Mar, E-08003 Barcelona, Spain. · Oncology and Hematology Department, Health Research Institute University Clinic Hospital of Valencia (INCLIVA), University of Valencia, E-46010 Valencia, Spain. · Pubmed 27993109
  • Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia. · The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia. · St Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, NSW, 2010, Australia. · The Chris O' Brien Lifehouse, Camperdown, NSW, 2050, Australia. · Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia. · MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Bristol, BS8 2BN, UK. · Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, SA, 5000, Australia. · Faculty of Health Sciences, School of Medicine, University of Adelaide, Adelaide, SA, 5000, Australia. · Pathology Queensland and School of Medicine, University of Queensland, St Lucia, QLD, 4006, Australia. · Rajiv Gandhi Centre for Biotechnology, Thycaud Post, Poojappura, Thiruvananthapuram, Kerala, 695014, India. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, 41013, Sevilla, Spain. · Department of Pathology, Hospital Universitario Fundación Jiménez Díaz, 28040, Madrid, Spain. · Department of Medical Oncology, Hospital Clínico Universitario Virgen de la Victoria, IBIMA, 29010, Málaga, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, 28703, Spain. · St Vincent's Hospital, 2010, Darlinghurst, NSW, Australia. · Department of Medical Oncology, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, 28040, Madrid, Spain. · Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia. · The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia. · St Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, NSW, 2010, Australia. · Pubmed 30042390
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. Electronic address: · Medical Oncology Service, Hospital Universitario Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK. · Department of Pathology, Seoul National University Bundang Hospital, 82, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam, Gyeonggi 13620, Republic of Korea; Inivata, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. · Inivata UK, The Portway Building, Granta Park, Cambridge CB21 6GS, UK. · Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ, UK. · Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea. · Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. · Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain; GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain. · Medical Oncology Service, Hospital Universitario Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain; Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. Electronic address: · Pubmed 29608913
  • Departamento de Anatomía Patológica, Hospital Universitario Ramón y Cajal, CIBERONC, IRYCIS, Universidad de Alcalá, Madrid, España. Electronic address: · Departamento de Oncología Médica, Hospital del Mar, Instituto de Investigación Médica del Hospital del Mar (IMIM), Universidad Pompeu Fabra, CIBERONC, Barcelona, España. · Departamento de Anatomía Patológica, Hospital Universitario Fundación Jiménez Díaz, Madrid, España. · Departamento de Oncología Médica, Hospital Universitario 12 de Octubre, Madrid, España. · Departamento de Anatomía Patológica, Hospital General Universitario de Alicante, Alicante, España. · Departamento de Oncología Médica, Hospital Universitario Ramón y Cajal, Madrid, España; Instituto de Oncología Vall d'Hebron (VHIO), Instituto de Oncología Baselga (IOB), Barcelona, España. · Departamento de Anatomía Patológica, Complexo Hospitalario de Santiago, Santiago de Compostela, La Coruña, España. · Departamento de Oncología Médica, Hospital Universitario Gregorio Marañón, CIBERONC, GEICAM, Madrid, España. · Departamento de Anatomía Patológica, Hospital Universitario Virgen del Rocío, CIBERONC, Sevilla, España. · Departamento de Oncología Médica, Hospital Universitario de la Princesa, Madrid, España. · Pubmed 29602380
  • Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. · CIBERONC, Madrid, Spain. · Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. · Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain. · Translational Genomics and Targeted Therapeutics, Institut d'Investigacions Biomèdiques Pi i Sunyer-IDIBAPS, Barcelona, Spain. · Experimental Therapeutics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain. · Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. · Department of Pathology, Yale University School of Medicine, Yale, CT, USA. · Department of Oncology, Vall d'Hebrón University Hospital, Barcelona, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Universitat Autònoma de Barcelona, Bellaterra, Spain. · ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain. · Ramon y Cajal University Hospital, Madrid, Spain. · Medical Oncology Service, Hospital del Mar, Barcelona, Spain. · Department of Oncology, Hospital Clinic de Barcelona, Barcelona, Spain. · Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain. · University of Valencia, Valencia, Spain. · INCLIVA, Instituto de Investigación Sanitaria, Valencia, Spain. · Universitat Pompeu Fabra, Barcelona, Spain. · Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. · CIBERONC, Madrid, Spain. · ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain. · Universitat de Barcelona, Barcelona, Spain. · Pubmed 29358704
2017
  • Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz, UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, Spain. Electronic address: · Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz, UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, Spain. · Pathology Department, IIS "Fundación Jiménez Diaz", Madrid, Spain. · Pathology Department, IIS "Fundación Jiménez Diaz", Madrid, Spain. Electronic address: · Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz, UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, Spain. Electronic address: · Pubmed 28916342
  • Hospital Universitario Virgen Macarena, Seville, Spain. Electronic address: · GEICAM (Spanish Breast Cancer Research Group), Madrid, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Medical School, Hospital Universitario Virgen Macarena, Seville, Spain. · Pubmed 28325210
  • Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK. Electronic address: · Clinical Trials Research Unit, University of Leeds, Leeds, UK. · IMIM-CIBERONC, Barcelona; Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain. · Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Deakin University, Geelong, VIC, Australia. · Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK. · St James Institute of Oncology, St James Hospital, Leeds, UK. · Inbiomotion, Barcelona, Spain. · Fundación Jiménez Díaz, Madrid, Spain; CIBERONC, Madrid, Spain. · IMIM-CIBERONC, Barcelona; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. · Pubmed 29037984
  • Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain, on behalf of GEICAM (Spanish Breast Cancer Group), Spain. · Oncology Department, Hospital Universitario Virgen de la Salud, Toledo, Spain. · Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Oncology Department, Onkologikoa, San Sebastián, Spain. · Oncology Department, Hospital General Universitario Morales Messeguer, Murcia, Spain. · Oncology Department, Corporación Sanitaria Parc Taulí, Barcelona, Spain. · Oncology Department, Complejo Hospitalario de Jaén, Jaén, Spain. · Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Oncology Department, Complejo Hospitalario Universitario de la Coruña, La Coruña, Spain. · Oncology Department, Hospital Universitario la Paz, Madrid, Spain. · Medical Oncology Department, Hospital de Santa Creu i Sant Pau, Institut de Recerca IIB Sant Pau, Barcelona, Spain. · Oncology Department, Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife, Spain. · Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain. · Oncology Department, Hospital Clinic i Provincial, Barcelona, Spain. · GEICAM headquarters, Madrid, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 28701571
  • Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Medical Oncology Department, Hospital del Mar- CIBERONC, Barcelona, Spain. · Centro de Investigación del Cáncer, Universidad de Salamanca-CSIC-CIBERONC, Salamanca, Spain. · Pathology Department, Hospital del Mar, Barcelona, Spain. · Immunity and infection Laboratory, IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Pathology Department, IIS-Fundación Jiménez Díaz- CIBERONC, Madrid, Spain. · INCLIVA Biomedical Research Institute, Valencia, Spain. · Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO)-CIBERONC, Barcelona, Spain. · Autonomous University of Barcelona, Barcelona, Spain. · Institució Catalana de Recerca I Estudis Avançats (ICREA), Barcelona, Spain. · Oncology and Hematology Department, Hospital Clínico Universitario-CIBERONC, Valencia, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Universitat Pompeu Fabra, Barcelona, Spain. · Pubmed 28821558
  • Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain. · Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy. · Medical Oncology Deparment, Arnau de Vilanova de Lleida Universitary Hospital, Lleida, Spain. · Medical Oncology Department, Reina Sofía University Hospital, Cordoba, Spain. · Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Universidad Complutense, Madrid, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Medical Oncology Department, Quirón Hospital, Madrid, Spain. · Master of Breast Pathology, University of Barcelona, Barcelona, Spain. · Pathology Department, Fundación Jiménez Díaz Health Research Institute (IIS-FJD), Madrid, Spain. · Medical Oncology Department, Doce de Octubre Hospital, Madrid, Spain. · Medical Oncology Department, Hospital del Mar, Barcelona, Spain. · Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain. · Medical Oncology Department, Mutua de Terrassa Hospital, Barcelona, Spain. · Spanish Breast Cancer Research Group Grupo Español de Investigación en Cáncer de Mama (GEICAM), Madrid, Spain. · Pubmed 28423537
  • Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain. · Hospital Provincial de Castellón, Castellón, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Pathology, Hospital Clínico Universitario de Valencia, Spain. · Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Hospital Clínico San Cecilio, Complejo Hospitalario de Granada, Granada, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Universitario Quirón de Madrid, Madrid, Spain. · Hospital Virgen de la Salud, Toledo, Spain. · Pathology Department, Hospital Vall d'Hebron, Barcelona, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · University of North Carolina, Chapel Hill, North Carolina. · Ramón y Cajal University Hospital, Madrid, Spain. · University of Messina, Messina, Italy. · Hospital del Mar, Barcelona, Spain. · ICREA, Barcelona, Spain. · Department of Hematology and Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Pubmed 28249905
  • INCLIVA Biomedical Research Institute, 46010 Valencia, Spain. · Pathology Department, IIS-Fundación Jiménez Díaz, 28040 Madrid, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), 08003 Barcelona, Spain. · Medical Oncology Department, Hospital del Mar, 08003 Barcelona, Spain. · Pompeu Fabra University, 08002 Barcelona, Spain. · Oncology and Hematology Department, Hospital Clínico Universitario, 46010 Valencia, Spain. · Pubmed 28120942
  • Department of Medical Oncology, Translational Oncology Division, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital 'Fundacion Jimenez Diaz', Madrid, Spain. · Department of Pathology, IIS 'Fundación Jiménez Diaz', Madrid, Spain. · Department of Breast Cancer Research, Institute of Health Research INCLIVA, Valencia, Spain. · Department of Medical Oncology, Hospital del Mar, Barcelona, Spain. · Pubmed 28068327
  • Translational Oncology DivisionOncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital 'Fundacion Jimenez Diaz', Madrid, Spain · Translational Oncology DivisionOncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital 'Fundacion Jimenez Diaz', Madrid, Spain. · Pathology DepartmentIIS-Fundacion Jimenez Diaz-UAM, University Hospital 'Fundacion Jimenez Diaz', Madrid, Spain. · Pubmed 27765801
2016
  • Pathology Department, IIS-Fundación Jiménez Díaz, UAM, Madrid, Spain. · Translational Oncology Division, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital Fundación Jiménez Díaz, Madrid, Spain. · "Alberto Sols" Biomedical Research Institute CSIC-UAM, Madrid, Spain. · Institute of Health Research INCLIVA, Valencia, Spain. · Medical Oncology Department, Hospital del Mar, Barcelona, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Universitat Pompeu Fabra, Barcelona, Spain. · Pathology Department, IIS-Fundación Jiménez Díaz, UAM, Madrid, Spain. · Pubmed 27599524
  • Pathology Department, IIS-Fundación Jiménez Díaz, 28040 Madrid, Spain. · Research Unit on Biomedical Informatics-GRIB, IMIM 08003 Barcelona, Spain. · INCLIVA Biomedical Research Institute, 46010 Valencia, Spain. · Pathology Department Hospital General Universitario de Castellón, 12004 Castellón, Spain. · Pathology Department, Hospital Clinico Universitario, 46010 Valencia, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), 08003 Barcelona, Spain. · Medical Oncology Department, Hospital del Mar, 08003 Barcelona, Spain. · Universitat Pompeu Fabra, 08002 Barcelona, Spain. · Oncology and Hematology Department, Hospital Clinico Universitario, 46010 Valencia, Spain. · Pubmed 27404455
  • Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona 08028, Spain. · Cancer Research Programme, IMIM (Hospital del Mar Medical Research Institute), Barcelona 08003 Spain. · Pathology Department, IIS-Fundación Jimenez Diaz, Madrid 28040, Spain. · Centre for Omic Sciences, Universitat Rovira i Virgili, Reus 43204, Spain. · Department of Electronic Engineering, Universitat Rovira i Virgili, Tarragona 43003, Spain. · Spanish Biomedical Research Center in Diabetes and Associated Metabolic Disorders (CIBERDEM), Madrid 28029, Spain. · Medical Oncology Service, Hospital del Mar, Barcelona 08003, Spain. · Medical Oncology Service, Hospital Clinico, Valencia 46010, Spain. · Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona 08010, Spain. · Universitat Pompeu Fabra, Barcelona 08003, Spain. · Department of Biochemistry and Molecular Biology, Universitat de Barcelona, Barcelona 08028, Spain. · Pubmed 27045898
  • Virgen de la Victoria University Hospital, Málaga, Spain · Valencia University Hospital, Valencia, Spain. · Virgen de la Victoria University Hospital, Málaga, Spain. · Miguel Servet University Hospital, Zaragoza, Spain. · Jaén Hospital Complex, Jaen, Spain. · Hospital del Mar Medical Research Institute-Institut Hospital del Mar d'Investigacions Mediques and Pompeu Fabra University, Barcelona, Spain. · A Coruña University Hospital Complex, A Coruña, Spain. · San Carlos University Hospial, Madrid, Spain. · Ramón y Cajal University Hospital, Madrid, Spain. · Virgen de la Salud Hospital, Toledo, Spain. · Valencian Institute of Oncology, Valencia, Spain. · Biomedical Research Institute, Reina Sofía Hospital Complex, Córdoba, Spain. · Parc Taulí Health Corporation, Barcelona, Spain. · Germans Trias i Pujol University Hospital, Barcelona, Spain. · Onkologikoa, Donostia, Spain. · Santa Creu i Sant Pau Hospital, Barcelona, Spain. · GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain. · Fundación Jiménez Diaz University Hospital, Madrid, Spain. · Pubmed 26786263
2015
  • Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain · Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain · Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR) · Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA) · Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL) · Valencia Central University, Spain (AL) · Inbiomotion, Barcelona, Spain (JJM) · Sheffield Cancer Research Centre, Sheffield, UK (RC) · Universitat Pompeu Fabra, Barcelona, Spain (JA) · Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP) · Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA) · Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG). · Pubmed 26376684
  • Translational Oncology Division, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital "Fundación Jiménez Diaz", Madrid, Spain. · Pathology Department, IIS "Fundación Jiménez Diaz", Madrid, Spain. · Medical Oncology Department, Hospital del Mar, Barcelona, Spain. · Institute of Health Research INCLIVA, Valencia, Spain. · Pubmed 25726524
2014
  • Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga 29010, Spain. · Hospital Parc de Salut Mar, 8003 Barcelona, Spain. · Hospital Universitario Reina Sofía, 14004 Córdoba, Spain. · Hospital Santa Creu i Sant Pau, Universidad Autónoma de Barcelona, 8041 Barcelona, Spain. · Complejo Hospitalario Universitario de A Coruña, 15006A Coruña, Spain. · Hospital General de Jaén, 23007 Jaén, Spain. · Centro Oncológico de Galicia, 15009A Coruña, Spain. · 1] Hospital Parc de Salut Mar, 8003 Barcelona, Spain [2] Department of Pathology, Fundación Jiménez Díaz, 28040 Madrid, Spain. · Department of Pathology and Oncology, Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain. · GEICAM (Spanish Breast Cancer Research Group), 28703 Madrid, Spain. · Pubmed 24457911
  • Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain; Medical Oncology Department, Hospital del Mar, Barcelona, Spain. · Preclinical Research Program, Valld'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pathology Department, IIS-Fundación Jiménez Díaz, Madrid, Spain. · Institute of Health Research INCLIVA, Valencia, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain; Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Autonomous University of Barcelona, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain; Immunology Department, Hospital del Mar, Barcelona, Spain. · Oncology and Hematology Department, Hospital Clinico Universitario, Valencia, Spain; Valencia Central University, Spain. · Preclinical Research Program, Valld'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Department of Biochemistry and Molecular Biology, Universitat Autonoma de Barcelona, Bellaterra, Spain; Institució Catalana de Recerca I Estudis Avançats (ICREA), Barcelona, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jiménez Díaz, Madrid, Spain; Pathology Department, Hospital del Mar, Barcelona, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain; Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain. Electronic address: · Pubmed 25128455
  • Authors' Affiliations: Departments of Pathology and Immunology, IIS-Fundación Jiménez Díaz, Madrid; Cancer Research Program; Microarray Core Facility (SAM), IMIM (Hospital del Mar Medical Research Institute); Department of Epidemiology and Evaluation, Hospital del Mar; Research Network on Health Services in Chronic Diseases (REDISSEC); Departments of Pathology, Medical Oncology, and Radiology Department, Hospital del Mar; and Universitat Pompeu Fabra, Barcelona, Spain. · Pubmed 24347552
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
2016
  • Group of Cancer Biomarkers, Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain. · Pubmed 25789534
2013
  • Molecular Immunology Unit, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain. · Pubmed 23951338
Instituto de Salud Carlos III
2019
  • Department of Medical Oncology, Hospital Clínico San Carlos, Madrid and Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, 02006, Albacete, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Department of Medical Oncology, Institut Català d'Oncologia (ICO)-IDIBELL, L'Hospitalet, Barcelona, Spain. · Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Institute of Biomedical Reasearch in Malaga, Malaga, Spain. · Department of Medical Oncology, Fundación Onkologikoa, Donostia, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Instituto de Biología Molecular y Celular del Cáncer, IBSAL, CSIC-Universidad de Salamanca, Salamanca, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 30607629
2018
  • Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. · CIBERONC, Madrid, Spain. · Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. · Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain. · Translational Genomics and Targeted Therapeutics, Institut d'Investigacions Biomèdiques Pi i Sunyer-IDIBAPS, Barcelona, Spain. · Experimental Therapeutics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain. · Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. · Department of Pathology, Yale University School of Medicine, Yale, CT, USA. · Department of Oncology, Vall d'Hebrón University Hospital, Barcelona, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Universitat Autònoma de Barcelona, Bellaterra, Spain. · ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain. · Ramon y Cajal University Hospital, Madrid, Spain. · Medical Oncology Service, Hospital del Mar, Barcelona, Spain. · Department of Oncology, Hospital Clinic de Barcelona, Barcelona, Spain. · Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain. · University of Valencia, Valencia, Spain. · INCLIVA, Instituto de Investigación Sanitaria, Valencia, Spain. · Universitat Pompeu Fabra, Barcelona, Spain. · Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. · CIBERONC, Madrid, Spain. · ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain. · Universitat de Barcelona, Barcelona, Spain. · Pubmed 29358704
2017
  • Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK. Electronic address: · Clinical Trials Research Unit, University of Leeds, Leeds, UK. · IMIM-CIBERONC, Barcelona; Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain. · Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Deakin University, Geelong, VIC, Australia. · Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK. · St James Institute of Oncology, St James Hospital, Leeds, UK. · Inbiomotion, Barcelona, Spain. · Fundación Jiménez Díaz, Madrid, Spain; CIBERONC, Madrid, Spain. · IMIM-CIBERONC, Barcelona; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. · Pubmed 29037984
  • Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain, on behalf of GEICAM (Spanish Breast Cancer Group), Spain. · Oncology Department, Hospital Universitario Virgen de la Salud, Toledo, Spain. · Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Oncology Department, Onkologikoa, San Sebastián, Spain. · Oncology Department, Hospital General Universitario Morales Messeguer, Murcia, Spain. · Oncology Department, Corporación Sanitaria Parc Taulí, Barcelona, Spain. · Oncology Department, Complejo Hospitalario de Jaén, Jaén, Spain. · Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Oncology Department, Complejo Hospitalario Universitario de la Coruña, La Coruña, Spain. · Oncology Department, Hospital Universitario la Paz, Madrid, Spain. · Medical Oncology Department, Hospital de Santa Creu i Sant Pau, Institut de Recerca IIB Sant Pau, Barcelona, Spain. · Oncology Department, Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife, Spain. · Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain. · Oncology Department, Hospital Clinic i Provincial, Barcelona, Spain. · GEICAM headquarters, Madrid, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 28701571
  • Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Medical Oncology Department, Hospital del Mar- CIBERONC, Barcelona, Spain. · Centro de Investigación del Cáncer, Universidad de Salamanca-CSIC-CIBERONC, Salamanca, Spain. · Pathology Department, Hospital del Mar, Barcelona, Spain. · Immunity and infection Laboratory, IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Pathology Department, IIS-Fundación Jiménez Díaz- CIBERONC, Madrid, Spain. · INCLIVA Biomedical Research Institute, Valencia, Spain. · Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO)-CIBERONC, Barcelona, Spain. · Autonomous University of Barcelona, Barcelona, Spain. · Institució Catalana de Recerca I Estudis Avançats (ICREA), Barcelona, Spain. · Oncology and Hematology Department, Hospital Clínico Universitario-CIBERONC, Valencia, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Universitat Pompeu Fabra, Barcelona, Spain. · Pubmed 28821558
  • Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain. · Hospital Provincial de Castellón, Castellón, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Pathology, Hospital Clínico Universitario de Valencia, Spain. · Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Hospital Clínico San Cecilio, Complejo Hospitalario de Granada, Granada, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Universitario Quirón de Madrid, Madrid, Spain. · Hospital Virgen de la Salud, Toledo, Spain. · Pathology Department, Hospital Vall d'Hebron, Barcelona, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · University of North Carolina, Chapel Hill, North Carolina. · Ramón y Cajal University Hospital, Madrid, Spain. · University of Messina, Messina, Italy. · Hospital del Mar, Barcelona, Spain. · ICREA, Barcelona, Spain. · Department of Hematology and Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Pubmed 28249905
Miscellaneous institutions in Madrid
2019
  • Department of Medical Oncology, Hospital Clínico San Carlos, Madrid and Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, 02006, Albacete, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Department of Medical Oncology, Institut Català d'Oncologia (ICO)-IDIBELL, L'Hospitalet, Barcelona, Spain. · Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Institute of Biomedical Reasearch in Malaga, Malaga, Spain. · Department of Medical Oncology, Fundación Onkologikoa, Donostia, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Instituto de Biología Molecular y Celular del Cáncer, IBSAL, CSIC-Universidad de Salamanca, Salamanca, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 30607629
2017
  • Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain. · Hospital Provincial de Castellón, Castellón, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Pathology, Hospital Clínico Universitario de Valencia, Spain. · Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Hospital Clínico San Cecilio, Complejo Hospitalario de Granada, Granada, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Universitario Quirón de Madrid, Madrid, Spain. · Hospital Virgen de la Salud, Toledo, Spain. · Pathology Department, Hospital Vall d'Hebron, Barcelona, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · University of North Carolina, Chapel Hill, North Carolina. · Ramón y Cajal University Hospital, Madrid, Spain. · University of Messina, Messina, Italy. · Hospital del Mar, Barcelona, Spain. · ICREA, Barcelona, Spain. · Department of Hematology and Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Pubmed 28249905
Hospital del Mar
2018
  • Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. · CIBERONC, Madrid, Spain. · Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. · Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain. · Translational Genomics and Targeted Therapeutics, Institut d'Investigacions Biomèdiques Pi i Sunyer-IDIBAPS, Barcelona, Spain. · Experimental Therapeutics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain. · Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. · Department of Pathology, Yale University School of Medicine, Yale, CT, USA. · Department of Oncology, Vall d'Hebrón University Hospital, Barcelona, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Universitat Autònoma de Barcelona, Bellaterra, Spain. · ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain. · Ramon y Cajal University Hospital, Madrid, Spain. · Medical Oncology Service, Hospital del Mar, Barcelona, Spain. · Department of Oncology, Hospital Clinic de Barcelona, Barcelona, Spain. · Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain. · University of Valencia, Valencia, Spain. · INCLIVA, Instituto de Investigación Sanitaria, Valencia, Spain. · Universitat Pompeu Fabra, Barcelona, Spain. · Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. · CIBERONC, Madrid, Spain. · ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain. · Universitat de Barcelona, Barcelona, Spain. · Pubmed 29358704
2016
  • Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona 08028, Spain. · Cancer Research Programme, IMIM (Hospital del Mar Medical Research Institute), Barcelona 08003 Spain. · Pathology Department, IIS-Fundación Jimenez Diaz, Madrid 28040, Spain. · Centre for Omic Sciences, Universitat Rovira i Virgili, Reus 43204, Spain. · Department of Electronic Engineering, Universitat Rovira i Virgili, Tarragona 43003, Spain. · Spanish Biomedical Research Center in Diabetes and Associated Metabolic Disorders (CIBERDEM), Madrid 28029, Spain. · Medical Oncology Service, Hospital del Mar, Barcelona 08003, Spain. · Medical Oncology Service, Hospital Clinico, Valencia 46010, Spain. · Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona 08010, Spain. · Universitat Pompeu Fabra, Barcelona 08003, Spain. · Department of Biochemistry and Molecular Biology, Universitat de Barcelona, Barcelona 08028, Spain. · Pubmed 27045898
2015
  • Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain · Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain · Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR) · Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA) · Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL) · Valencia Central University, Spain (AL) · Inbiomotion, Barcelona, Spain (JJM) · Sheffield Cancer Research Centre, Sheffield, UK (RC) · Universitat Pompeu Fabra, Barcelona, Spain (JA) · Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP) · Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA) · Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG). · Pubmed 26376684
  • Translational Oncology Division, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital "Fundación Jiménez Diaz", Madrid, Spain. · Pathology Department, IIS "Fundación Jiménez Diaz", Madrid, Spain. · Medical Oncology Department, Hospital del Mar, Barcelona, Spain. · Institute of Health Research INCLIVA, Valencia, Spain. · Pubmed 25726524
2014
  • Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain; Medical Oncology Department, Hospital del Mar, Barcelona, Spain. · Preclinical Research Program, Valld'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pathology Department, IIS-Fundación Jiménez Díaz, Madrid, Spain. · Institute of Health Research INCLIVA, Valencia, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain; Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Autonomous University of Barcelona, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain; Immunology Department, Hospital del Mar, Barcelona, Spain. · Oncology and Hematology Department, Hospital Clinico Universitario, Valencia, Spain; Valencia Central University, Spain. · Preclinical Research Program, Valld'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Department of Biochemistry and Molecular Biology, Universitat Autonoma de Barcelona, Bellaterra, Spain; Institució Catalana de Recerca I Estudis Avançats (ICREA), Barcelona, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jiménez Díaz, Madrid, Spain; Pathology Department, Hospital del Mar, Barcelona, Spain. · Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain; Medical Oncology Department, Hospital del Mar, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain. Electronic address: · Pubmed 25128455
  • Authors' Affiliations: Departments of Pathology and Immunology, IIS-Fundación Jiménez Díaz, Madrid; Cancer Research Program; Microarray Core Facility (SAM), IMIM (Hospital del Mar Medical Research Institute); Department of Epidemiology and Evaluation, Hospital del Mar; Research Network on Health Services in Chronic Diseases (REDISSEC); Departments of Pathology, Medical Oncology, and Radiology Department, Hospital del Mar; and Universitat Pompeu Fabra, Barcelona, Spain. · Pubmed 24347552
2012
  • Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Pubmed 21908496
2014
  • Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Pubmed 24344116
2013
  • Departamento de Oncología Médica, Hospital del Mar, Barcelona, España. · Pubmed 23809407
2012
  • Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain. · Pubmed 22675457
  • Pathology Service, Molecular Cytogenetics Laboratory, Hospital del Mar, IMIM, Barcelona, Spain. · Pubmed 22559974
  • Medical Oncology Service, Hospital del Mar, Barcelona, Spain. · Pubmed 21652577
Universidad Pompeu Fabra
2014
  • Authors' Affiliations: Departments of Pathology and Immunology, IIS-Fundación Jiménez Díaz, Madrid; Cancer Research Program; Microarray Core Facility (SAM), IMIM (Hospital del Mar Medical Research Institute); Department of Epidemiology and Evaluation, Hospital del Mar; Research Network on Health Services in Chronic Diseases (REDISSEC); Departments of Pathology, Medical Oncology, and Radiology Department, Hospital del Mar; and Universitat Pompeu Fabra, Barcelona, Spain. · Pubmed 24347552
79 Other Locations Show
Yearly article counts 171153426100